Skip to main content
Patients Referrer
 
Book Online Call Now Modify Booking
Image
https://www.qscan.com.au/wp-content/uploads/2022/08/Dr-Kevin-Lee-website.png

Dr Kevin
Lee

BSc (Medicine), MBBS, MHS (Clin Epi), FRACP (Endocrinology & Nuclear Medicine)
Endocrinologist & Nuclear Medicine Physician
Specialties and interests
  • Neurology, nuclear medicine and PET
  • Cardiometabolic
  • Bone health
  • Endocrine conditions
  • Theranostics in prostate cancer
  • Dementia imaging
About

Dr Kevin Lee is a private Endocrinologist and Nuclear Medicine Physician. He has been working with Qscan Radiology Clinics since 2018 in Queensland, Canberra and telemedicine in regional New South Wales and South Australia.

Kevin completed his undergraduate medical training at UNSW and his postgraduate training in Queensland. He also has a Master of Health Studies in Clinical Epidemiology from the University of Queensland. 

Kevin is a specialist with multispecialty knowledge and experiences, interested in dementia imaging, theranostics and oncology imaging. He has been involved in various oncology MDTs and has experience in theranostics for prostate cancer, neuroendocrine cancer, and thyroid cancer.

Other positions
  • Epilepsy MDT
  • Dementia MDT, metro-north
  • Private Endocrinologist

News & Articles

 

Your Qscan Reports Are Now in My Health Record — Here's What It Means for You

Managing your health has always required juggling paperwork, referrals, test results, scan reports passed between spe

Radiology in Lung Cancer: Evolving roles in screening, staging, and restaging

Lung cancer remains the leading cause of cancer-related mortality globally.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Your Qscan Reports Are Now in My Health Record — Here's What It Means for You

Managing your health has always required juggling paperwork, referrals, test results, scan reports passed between spe

Radiology in Lung Cancer: Evolving roles in screening, staging, and restaging

Lung cancer remains the leading cause of cancer-related mortality globally.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.